-
MAPPING THE EVIDENCE REQUIREMENTS FOR HEALTH TECHNOLOGY ASSESSMENT (HTA) BODY METHODOLOGICAL STANDARDS FOR SYSTEMATIC LITERATURE REVIEWS (SLRS) ACROSS KEY MARKETS
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH SEVERE ASTHMA TREATED WITH TEZEPELUMAB IN SPAIN. INSIGHT FROM THE T-ROSS II STUDY
Aug 11, 2026, 17:16 PM -
MANAGED ENTRY AGREEMENTS (MEAS) IN GREECE: STAKEHOLDER PERSPECTIVES ON OUTCOME-BASED REIMBURSEMENT AND HEALTHCARE SYSTEM READINESS
Aug 11, 2026, 17:16 PM -
PAYING BEYOND COVERAGE: NATIONWIDE REGISTER EVIDENCE ON OUTPATIENT CANCER MEDICINE COSTS AND REIMBURSEMENT IN FINLAND
Aug 11, 2026, 17:16 PM -
MAKING THE BEST OUT OF AVAILABLE REGULATED PRICE OPTIONS FOR MEDICINAL PRODUCTS (MPS) FOR HUMAN USE IN SLOVENIA: EXCEPTIONAL HIGHER ALLOWED PRICE (EHAP) AND INVISIBLE MAXIMUM ALLOWED PRICE (IMAP)
Aug 11, 2026, 17:16 PM -
PICO PROVENANCE EVALUATING AI TRACEABILITY FOR EU JOINT CLINICAL ASSESSMENTS
Aug 11, 2026, 17:16 PM -
HEALTH STATE UTILITIES FOR CLINICAL EVENTS IN ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
MULTIDISCIPLINARY ASSESSMENT OF HEALTHCARE PROFESSIONALS' ADOPTION WILLINGNESS, BARRIERS, AND FACILITATORS FOR DUCHENNE MUSCULAR DYSTROPHY GENE THERAPY IN SPAIN
Aug 11, 2026, 17:16 PM -
DUPILUMAB REDUCES EXACERBATIONS WHILE IMPROVING LUNG FUNCTION AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND TYPE 2 INFLAMMATION, REGARDLESS OF SMOKING STATUS
Aug 11, 2026, 17:16 PM -
LEVERAGING AI PLATFORMS TO ANTICIPATE EU JCA DOSSIER RISKS: INSIGHTS FROM EARLY TERMINATIONS
Aug 11, 2026, 17:16 PM -
ONLINE PROBLEM GAMBLING AMONG YOUNG ADULTS IN GREECE
Aug 11, 2026, 17:16 PM -
PAN-EUROPEAN EVIDENCE OF ROBOTIC-ASSISTED SURGERY USING THE DA VINCI SURGICAL SYSTEM FOR BENIGN PROCEDURES: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Aug 11, 2026, 17:16 PM -
APPLICATION OF A MULTI-CRITERIA DECISION ANALYSIS FRAMEWORK FOR THE OPTIMISATION OF A COMPLEX PARENTING INTERVENTION IN SOUTHEAST EUROPE: A COST-CONSEQUENCES ANALYSIS OF THE FLOURISH FACTORIAL TRIAL
Aug 11, 2026, 17:16 PM -
BEYOND MAIC: LEVERAGING ML-NMR FOR PARAMETRIC SURVIVAL EXTRAPOLATION IN INDIRECT TREATMENT COMPARISONS
Aug 11, 2026, 17:16 PM -
BURDEN OF CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) IN PATIENTS AT HIGH RISK OF RECURRENCE IN SPAIN
Aug 11, 2026, 17:16 PM -
FEASIBILITY ASSESSMENT OF UNANCHORED INDIRECT TREATMENT COMPARISON OF ASCIMINIB VERSUS SECOND-GENERATION TKIS IN SECOND-LINE SETTING FOR PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
Aug 11, 2026, 17:16 PM -
THE IMPACT OF MATURE VERSUS IMMATURE SURVIVAL DATA ON COST-EFFECTIVENESS ESTIMATES IN ONCOLOGY: A NICE CASE STUDY
Aug 11, 2026, 17:16 PM -
IMPACT OF MODELING LOSS OF EXCLUSIVITY ON COST-EFFECTIVENESS IN ULCERATIVE COLITIS IN THE UK
Aug 11, 2026, 17:16 PM -
PNEUMOCOCCAL VACCINATION STRATEGIES IN OLDER ADULTS IN VIETNAM ACCOUNTING FOR CHILDHOOD VACCINATION EFFECTS: A COST-EFFECTIVENESS ANALYSIS USING A DYNAMIC TRANSMISSION MODEL
Aug 11, 2026, 17:16 PM -
EVALUATING RANDOM SURVIVAL FOREST FOR LONG-TERM SURVIVAL EXTRAPOLATION BY COMBINING TRIAL-LIKE AND REAL-WORLD-LIKE COHORTS DERIVED FROM A SINGLE LUNG CANCER DATASET
Aug 11, 2026, 17:16 PM
